Health Policy Transformation
The LMI Health Equity Collaborative facilitates equity, justice, and other improvements in federal health care delivery.
Health care is evolving into a model that is increasingly patient-centered, value-based, and coordinated across services. The LMI Health Equity Collaborative works to eliminate health disparities and empower communities and special populations to develop, implement, and evaluate health programs through research, education, training, advocacy, and the practical application of evaluation principles and methods. The LMI Way of Policy provides a structured process to identify opportunities where LMI can differentiate and provide innovative solutions to address the government’s toughest problems.
-
The New Speed of Possible™Health & Civilian
Our subject matter experts and advisors have a broad knowledge base across the spectrum of federal health and civilian agencies to enable excellence in execution that transcends boundaries.
More About Our Health & Civilian Market
Zaki Saleh
Sr. Vice President, Health & Civilian MarketZaki Saleh leads LMI’s health & civilian market, where he is responsible for profit and loss management and business growth, overseeing project delivery, execution, and overall customer satisfaction as well as the business development function.
Related Content
Explore All-
InsightsLMI’s Merrill Harmison on Health Equity and Accountable Care Organizations
LMI provides strategic support to CMS to facilitate the implementation of the Medicare Shared Savings Program. This consists of overseeing and reviewing applications submitted by prospective Accountable Care Organizations (ACOs) and conducting ongoing monitoring and compliance checks for ACOs participating in the program.
-
Press ReleaseLMI Selected to Support the Food and Drug Administration Business Operations, Optimization, and Modernization BPA
LMI will support the FDA through the BOOM BPA, in optimizing and modernizing its business operations to align with strategic priorities and increase the effectiveness of FDA organizations.
